Using population‐based cancer registry data, the present study documents the changes in prostate cancer incidence trends coinciding with the release of the PLCO and ERSPC studies and recent USPSTF PSA screening recommendations by month of diagnosis. This evidence concerns the gene KLK3 and prostate cancer.